Impaired mismatch negativity generation in prodromal subjects and patients with schizophrenia

https://doi.org/10.1016/j.schres.2004.05.016Get rights and content

Abstract

Background

Mismatch negativity (MMN) specifically the response to tone duration deviants has consistently been shown to be reduced in schizophrenia suggesting dysfunction in auditory sensory memory.

As part of a multidimensional approach to the early recognition of psychosis, MMN was investigated as a possible risk factor for later development of psychosis in subjects with a prodromal syndrome. Forty-three prodromal subjects, 31 neuroleptic-free inpatients with schizophrenia and 33 healthy controls were studied. A prodromal state was defined by a cluster ‘Cognitive Disturbances’ as defined by the ‘Bonn Scale for the Assessment of Basic Symptomsʼ (BSABS), which was found highly predictive of first-episode schizophrenia. To elicit MMN, a three-tone auditory oddball paradigm with 10% ‘duration deviants’ and 10% ‘frequency deviants’ was used.

Results

MMN amplitudes to tone duration deviants were significantly reduced in the patients with schizophrenia compared to controls. The putatively prodromal subjects also showed a slight, though non-significant reduction of the MMN amplitude that was intermediate between normal controls and patients with schizophrenia, and with a larger within-group variance.

Conclusion

These results support the view that abnormalities in temporal processing are particularly pronounced in patients with schizophrenia. Prodromal subjects are a heterogeneous group with regard to outcome and time until transition to a first psychotic episode. Follow-up of these putatively prodromal subjects will show whether MMN amplitudes further reduce over time in those developing psychosis and if a reduction is state-dependent.

Introduction

Deficits in various domains of cognitive functioning are considered a core feature of schizophrenic psychoses (Goldberg and Gold, 1995). Furthermore, recent findings indicate that certain impairments in cognitive functioning precede the onset of the first psychotic episode and are already evident in persons who are considered to be at risk of psychosis (Hambrecht et al., 2002, Wood et al., 2003). To understand the biological basis of these cognitive deficits, the underlying neural correlates need to be investigated. Thus, event-related potentials (ERP) appear to be effective paradigms as they allow a real-time observation of neurophysiological processes while the subject is performing the respective cognitive task. Of the different ERP paradigms, mismatch negativity (MMN), a component of auditory ERP, has consistently been shown to clearly discriminate between patients with schizophrenia and controls (for review, see Mitchie, 2001), thus providing a promising starting-point for the investigation of neurobiological at-risk indicators in potentially prodromal subjects.

MMN has been interpreted as an index of automatic feature analysis in the auditory cortex, the so-called ‘echoic memory’ (Näätänen, 1990), with respect to temporal processing (Davalos et al., 2003). It is elicited as a response to rare deviant tones interspersed in the repeated presentation of a standard tone and is little affected by attention and motivation. While a reduced MMN amplitude in response to tone duration and tone frequency deviants, respectively, has been demonstrated for patients with schizophrenia in several studies (Shelley et al., 1991, Shelley et al., 1999, Javitt et al., 1993, Javitt et al., 1995, Javitt et al., 1998, Catts et al., 1995, Reite et al., 1996, Oades et al., 1996, Shutara et al., 1996), MMN response to tone duration deviants in particular seems to be impaired in schizophrenia (Mitchie et al., 2000, Mitchie, 2001, Umbricht et al., 2003).

To investigate the applicability of MMN as a neurobiological at-risk indicator reflecting an echoic memory disturbance, potentially prodromal subjects (PP), neuroleptic-free patients with schizophrenia (SP) and healthy controls (HC) were compared for the first time. It was assumed that, in comparison to healthy controls, those with schizophrenia would exhibit a large, significant reduction of the MMN amplitude, whereas the MMN amplitude of prodromal subjects would show a less pronounced though still detectable reduction, thereby holding an intermediate position between those with schizophrenia and healthy controls. Moreover, a larger group effect was expected on the MMN amplitude in response to tone duration deviants compared to that in response to tone frequency deviants. In addition, associations between MMN reduction and neuropsychological deficits were investigated to detect possible interactions of these two different levels of neurobiological functioning.

Section snippets

Subjects

Forty-three outpatients of the Cologne Early Recognition and Intervention Centre (FETZ) with a prodromal syndrome (PP) (mean±S.D.; age 25.4±5.8 years, gender (male/female): 29:14; school education 11.9±1.6 years) were included.

A prodromal state was defined by the presence of at least any two of nine self-experienced and self-reported subtle subclinical cognitive disturbances, i.e. basic symptoms, as assessed with the ‘Bonn Scale for the Assessment of Basic Symptoms’ (BSABS; Gross et al., 1987).

Results

The repeated measure ANOVA of the MMN peak amplitudes in response to duration and frequency deviants revealed significant group differences between neuroleptic-free patients with schizophrenia, prodromal subjects and controls over the six fronto-central electrodes (F (df)=3.134 (2.59); p=0.05; see Table 2, Fig. 1, Fig. 2, Fig. 3, Fig. 4, Fig. 5). The post hoc test demonstrated significant differences between controls and patients with schizophrenia with reduced MMN peak amplitudes in patients

Discussion

In the present study, we investigated whether MMN amplitudes might reflect the progression from a prodromal stage to schizophrenia. Consistent with previous reports (Shelley et al., 1991, Shelley et al., 1999, Javitt et al., 1993, Javitt et al., 1995, Javitt et al., 1998, Catts et al., 1995, Reite et al., 1996, Oades et al., 1996, Shutara et al., 1996), significantly reduced MMN amplitudes in neuroleptic-free patients with schizophrenia were found compared to healthy controls. In addition,

Acknowledgements

Preliminary results of this study have been presented as a poster during the European Regional Congress of the World Federation of Societies of Biological Psychiatry (WFSBP) in Copenhagen, Denmark, 16 June 2002. The authors have been awarded a Poster Prize for the presentation.

References (44)

  • Y. Sato et al.

    Impairment in activation of a frontal attention-switch mechanism in schizophrenic patients

    Biol. Psychol.

    (2003)
  • A.M. Shelley et al.

    Diminished responsiveness of ERPs in schizophrenic subjects to changes in auditory stimulation parameters: implications for theories of cortical dysfunction

    Schizophr. Res.

    (1999)
  • J. Todd et al.

    Auditory sensory memory in schizophrenia: inadequate trace formation?

    Psychiatry Res.

    (2000)
  • J. Todd et al.

    Association between reduced duration mismatch negativity (MMN) and raised temporal discrimination thresholds in schizophrenia

    Clin. Neurophysiol.

    (2003)
  • D. Umbricht et al.

    How specific are deficits in mismatch negativity generation to schizophrenia?

    Biol. Psychiatry

    (2003)
  • American Electroencephalographic Society

    Guidelines for standard electrode position nomenclature

    J. Clin. Neurophysiol.

    (1994)
  • S.V. Catts et al.

    Brain potential evidence for an auditory sensory memory deficit in schizophrenia

    Am. J. Psychiatry

    (1995)
  • J. Cohen

    Statistical Power Analysis for the Behavioral Science

    (1988)
  • D.B. Davalos et al.

    Mismatch negativity in detection of interval duration deviants in schizophrenia

    NeuroReport

    (2003)
  • M.B. First et al.

    Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I)

    (1997)
  • T.E. Goldberg et al.

    Neurocognitive functioning in patients with schizophrenia

  • G. Gross et al.

    Bonner Skala für die Beurteilung von Basissymptomen

    (1987)
  • Cited by (137)

    • Mismatch Negativity to Pitch and Duration Deviants Is Not a Biomarker of Psychosis Risk

      2024, Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
    • Electroencephalography and Event-Related Potential Biomarkers in Individuals at Clinical High Risk for Psychosis

      2020, Biological Psychiatry
      Citation Excerpt :

      There is some evidence that duration-deviant MMN (dMMN) may be more sensitive to schizophrenia than frequency-deviant MMN (42,44), particularly among first-episode patients (45), although some studies have not found this effect (44,46). Evidence of reduced amplitudes in CHR-P suggests that MMN is compromised prior to psychosis onset (36,47–58) (Cohen’s ds = 0.28–0.88), although some studies have failed to find such evidence (59–63) (Cohen’s ds = 0.0–0.32). In studies that also examined patients with schizophrenia, MMN amplitudes in CHR-P individuals were either intermediate between HC subjects and patients with schizophrenia (50,58,60) or similar to those of patients (36,47,52).

    View all citing articles on Scopus
    View full text